Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2005
10/06/2005US20050222073 Antisense modulation of thyroid hormone receptor interactor 6 expression
10/06/2005US20050222072 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
10/06/2005US20050222070 Pancreas-specific proteins
10/06/2005US20050222068 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
10/06/2005US20050222067 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell
10/06/2005US20050222066 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
10/06/2005US20050222065 Vascular therapeutics
10/06/2005US20050222064 Polycationic compositions for cellular delivery of polynucleotides
10/06/2005US20050222063 Methylenetetrahydrofolate reductase inhibitors and use thereof
10/06/2005US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/06/2005US20050222060 Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs
10/06/2005US20050222059 Egfrviii specific monoclonal antibody and egfrviii ribozymes and use to detect, treat or prevent egfrviii associated cancer
10/06/2005US20050222058 Antisense modulation of mucin 1, transmembrane expression
10/06/2005US20050222057 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
10/06/2005US20050222028 BMP-9 compositions and methods for inducing differentiation of cholinergic neurons
10/06/2005US20050222021 Immunomodulators; for treatment of inflammation
10/06/2005US20050222009 Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier
10/06/2005US20050221493 Recombinant virus production for the manufacturing of vaccines
10/06/2005US20050221492 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
10/06/2005US20050221489 Recombinant negative strand virus rna expression systems and vaccines
10/06/2005US20050221488 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods
10/06/2005US20050221458 proteins having oxidase or oxidoreductase activity, used to control growth of insects, enabling finer silk thread production; gene expression inhibition; genetic engineering
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221435 Biological material for preparing pharmaceutical compositions intended for treating mammals
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221394 Ion channel
10/06/2005US20050221388 Molecular interactions in hematopoietic cells
10/06/2005US20050221355 cDNA for human methylenetetrahydrofolate reductase and uses thereof
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221331 Osteoprotegerin
10/06/2005US20050221313 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith
10/06/2005US20050221292 Vectors with modified protease-dependent tropism
10/06/2005US20050221289 Altering viral tropism
10/06/2005US20050220858 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic
10/06/2005US20050220806 Method of transporting physiological polymer using protein having rxp repeated sequence
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220799 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
10/06/2005US20050220791 Novel of cytokine inhibitors
10/06/2005US20050220781 IFIX, a novel HIN-200 protein, for cancer therapy
10/06/2005US20050220774 Methods of inducing differentiation in ex vivo expanded stem cells
10/06/2005US20050220772 Stem cell screening and transplantation therapy for hiv infection
10/06/2005US20050220768 Materials and methods for treating ocular-related disorders
10/06/2005US20050220767 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
10/06/2005US20050220766 Viral vectors and methods for producing and using the same
10/06/2005US20050220765 Viruses with enhanced lytic potency
10/06/2005US20050220761 stimulating neural progenitor cells by culturing the cells ex vivo with a composition comprising IL6R/IL6 chimera, fused protein, functional derivative, circularly permutated derivative prior to transplantation; used for loss or atrophy of neurons caused by aging or by a neurological disease
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2561117A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005CA2560923A1 Annexin ii and uses thereof
10/06/2005CA2560827A1 Preventing arrhythmias associated with cell transplantation
10/06/2005CA2557426A1 Rab9a, rab11a, and modulators thereof related to infectious disease
10/05/2005EP1582596A2 Nor-1 (neuron-derived orphan receptor-1), novel diagnostic and therapeutic target for cardiovascular diseases
10/05/2005EP1582223A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy
10/05/2005EP1581812A2 Compositions and methods for diagnosing and treating colon cancers
10/05/2005EP1581637A2 Human stem cell materials and methods
10/05/2005EP1581635A2 Sirna-mediated gene silencing
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581610A2 Use of chimeric nucleases to stimulate gene targeting
10/05/2005EP1581552A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
10/05/2005EP1581307A2 Irs modulators
10/05/2005EP1581241A2 Stimulation of vascularization with vegf-b
10/05/2005EP1581201A1 Method for producing sterile polynucleotide based medicaments
10/05/2005EP1581095A2 Therapeutic methods for reducing fat deposition and treating associated conditions
10/05/2005EP1581056A2 Therapeutic retroviral vectors for gene therapy
10/05/2005EP1581054A2 Treatment of hsv-related patholgies using ssdna
10/05/2005EP1581053A1 Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene
10/05/2005EP1294393B1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1248654B1 Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
10/05/2005CN1678749A Non-human herpesviruses as vectors
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678344A Human papilloma virus treatment
10/05/2005CN1678338A Method and composition for regulating the activity of regulatory T cells
10/05/2005CN1678337A Amelioration of effects of cigarette smoke
10/05/2005CN1678188A Nucleic acid compositions for stimulating immune responses
10/05/2005CN1676610A Novel penicillium marneffei PPIase II, its coding sequence and use
10/05/2005CN1676609A Novel penicillium marnffei PPIase II, its coding sequence and use
10/05/2005CN1676608A Novel penicillium marneffei ERG1 gene, its coding protein and use
10/05/2005CN1676166A Ligand oligopeptide specific combining human epidermal growth factor receptor EGFR
10/05/2005CN1221666C Shuttle plasmid of adenovirus and its constructing method
10/05/2005CN1221665C Use of negative regulation elements for nerve-specific expression of transgenes
10/05/2005CN1221662C Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/05/2005CN1221285C Method for preparing genetically engineered nano vaccine for malignant tumour, such as liver cancer, stomach cancer and breast cancer
10/04/2005US6951939 Multivalent platform molecules comprising high molecular weight polyethylene oxide
10/04/2005US6951926 Antibody to bladder cancer nuclear matrix protein and its use
10/04/2005US6951924 Antibodies against secreted protein HTEBYII
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951845 Method for treating allergic lung disease
10/04/2005US6951756 Closure of bacterial ghost
10/04/2005US6951755 Vectors and methods for gene transfer
10/04/2005US6951732 Virulence genes, proteins, and their use
10/04/2005US6951721 Monitoring gene expression in cells; obtain cells, isolate genomic nucleotide sequences, determine genotype, determine the frequency of the genotype in cell pool, evaluate pattern of frequency
10/04/2005US6951653 Streptococcal C5a peptidase vaccine
10/04/2005US6951649 Methods of making neuraminidase-supplemented compositions
10/04/2005CA2166101C Drug delivery
1 ... 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 ... 870